Emulgel Formulation And Evaluation Utilizing Natural Polymer For Antifungal Activity
Keywords:
Emulgel, Emulsion, Fluconazole, AloeveraAbstract
Emulgel is a brand-new, innovative topical medication delivery technology that combines the benefits of hydrophilic gel and emulsions.Emulgel comprises both emulsions entrapped in polymer gel phase. To comprehend the drug and its behavior, preformulation research is carried out. Preformulation research included drug identification via DSC, FTIR, melting point, and solubility. To facilitate further drug calculations, a calibration curve for fluconazole in ethanol and pH 5.5 phosphate buffer is developed. Two approaches were used in the drug excipient compatibility investigation. Drug and drug excipient physical stability tests are conducted at room temperature and run for 14 and 28 days, respectively. The FTIR technique was used to verify the medication and polymer compatibility. The carbomer polymer and fluconazole are compatible.
For the creation of emulgel, carbomer homopolymer type C and aloevera are utilized. Aloevera demonstrated exceptional gelling qualities. Physical characteristics, rheological investigations, pH of the formulations, texture analyzer spreadability, bioadhesive strength assessment, extendability, drug content determination, and invitro drug release tests are all considered when evaluating formulations. The chosen formulation is stable for one month and was charged for the stability research at rapid, intermediate, and room temperature storage settings.
Downloads
References
Kenneth A, Michael S. The Structure and Function of Skin. Dermatological and Transdermal Formulations. Marcel Decker Inc, 2002; 01(01):01-39.
Michael S, Kenneth A. Skin Structure, Pharmaceuticals, Cosmetics, and the Efficacy of Topically Applied Agents. Dermatologic, Cosmetic, and Cosmetic Development, Therapeutic and Novel Approaches. Informa Healthcare USA, Inc, 2008; 01(01):01-10.
Ueda C, Shah V, Derdzinski K, Ewing G, Flynn G, Maibach H, Marques M, Rytting H, Shaw S, Thakker K, Yacobi A. Topical and Transdermal Drug Products. United states Pharmacopeia, 2009; 35(03):750-764.
Bhowmik D, Gopinath H, Kumar P, Duraivel S, Kumar S. Recent advances in Novel Topical Drug Delivery System. The Pharma innovation, 2012; 01(09):12- 31.
Singh D, Mital N, Kaur K. Topical Drug Delivery Systems: A Patent Review, Expert Opinion on Therapeutic Patents. Taylor & Francis Publisher, 2016; 26(02):213-228.
Bora A, Deshmukh S, Kapileswar S. Recent Advances in Semisolid Dosage Form. International Journal of Pharmaceutical Sciences and Research, 2014; 05(09):3594-3608.
Takeshi M, Masayuki A. Dissecting the formation, structure and barrier function of the stratum corneum. International Immunology, 2017; 29(05):243–244.
Valle M, Zamorani M. Skin and Subcutaneous Tissue. In: Ultrasound of the Musculoskeletal System. Medical Radiology (Diagnostic Imaging). Springer,
Menon G. Skin basics; Structure and functions. Springer International Publishing, 2015;01(01):09-18.
Menon G, Clearly G, Lane M. The structure and function of the stratum corneum. International Journal of Pharmaceutics, 2012; 435(01):03-09.
Wickett R, Visscher M. Structure and function of the epidermal barrier. American Journal of Infection Control, 2006; 34(10):98-110.
Estad M, Edwards C. Topical drug Products Development, Manufacture and Regulatory issues. Generic Drug Product Development: Specialty Dosage Forms. Informa Healthcare USA, Inc, 2010; 204(01):28-53.
Nair A, Jacob S, Al-Dhubaib B, Attimarad M, Harsha S. Basic considerations in the dermatokinetics of topical formulations. Brazilian Journal of Pharmaceutical Sciences, 2013; 49(03):424-433.
Pant S, Badola A, Baluni S, Pant W. A Review on Emulgel Novel Approach for Topical Drug Delivery System. World Journal of Pharmacy and Pharmaceutical Sciences, 2015; 04(10):1728-1743.
Shah A, Kamdar K, Shah R, Keraliya R, Emulgel: A Topical Preparation for Hydrophobic Drugs, Pharma Tech Medica, 2013;02(05):370-376.
Jones T, Tavakkol A. Safety and Tolerability of Luliconazole Solution 10-Percent in Patients with Moderate to Severe Distal Subungual Onychomycosis. Antimicrobial Agents and Chemotherapy, 2013; 57(06):2684-2689.
Kansagra H Mallick S. Microemulsion-based antifungal gel of luliconazole for dermatophyte infections: formulation, characterization and efficacy studies. Journal of Pharmaceutical Investigation, 2016; 46(01):21–28.
Masuda T, Kobayashi N, Sasagawa H. Pharmaceutical Composition. United States Patent, 2013; US8,513,296B2:01-11. 56. Chandana T, Saritha C, Shankaraiah P. Comparison of safety and efficacy of Laliconazole and other antifungal agents. International Journal of Pharma Sciences and Research, 2014; 05(01):01-09. 57. Desai N, Maheshwari D. UV Spectrophotometric Method for The Estimation of Luliconazole In Marketed Formulation (Lotion). An International Journal of Pharmaceutical Sciences, 2014; 05(02):48-54.
Gupta G, Kaur J, Kaur J, Jaiswal S. A Review on Novel Approach of Antifungal Emulgel for Topical Delivery In Fungal Infections. IAJPR, 2016; 6: 6312-324. 59. Lachman L, Lieberman HA, Kanig JL. The theory and practice of industrial pharmacy: Lea & Febiger, 1986.
Varma VNSK, Maheshwari P, Navya M, Reddy SC, Shivakumar H, Gowda D. Calcipotriol delivery into the skin as emulgel for effective permeation. Saudi Pharmaceutical Journal, 2014; 22(6): 591-9.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
